Related Experiment Video
Updated: Aug 4, 2026

Quantitation of Endothelial Cell Adhesiveness In Vitro
Published on: June 18, 2015
Effect of vitamin E supplementation on circulating cell adhesion molecules pre- and post-coronary angioplasty
G A Ferns1, L A Forster, J C Williams
1Department of Clinical Biochemistry, The Royal Surrey County Hospital, Guildford, UK. g.ferns@surrey.ac.uk
Insights
Vitamin E supplementation may reduce platelet and endothelial activation during percutaneous transluminal coronary angioplasty (PTCA). This study found vitamin E limited increases in soluble P-selectin and intercellular adhesion molecule-1 levels post-PTCA compared to placebo.
Area of Science:
- Cardiovascular Medicine
- Nutritional Science
- Biochemistry
Background:
- Soluble adhesion molecules, including P-selectin (sP-selectin) and intercellular adhesion molecule-1 (sICAM-1), are elevated in atherosclerosis and after percutaneous transluminal coronary angioplasty (PTCA).
- These molecules originate from platelets and endothelial cells, indicating cellular activation during vascular procedures.
Purpose of the Study:
- To investigate the effect of vitamin E supplementation on plasma levels of sICAM-1 and sP-selectin before and after PTCA.
- To determine if vitamin E can mitigate the increase in these soluble adhesion molecules typically observed post-PTCA.
Main Methods:
- A randomized controlled trial involving patients undergoing PTCA, pre-treated with either vitamin E (800 IU/day) or placebo for one month.
- Plasma levels of sICAM-1, sP-selectin, and alpha-tocopherol were measured using enzyme-linked immunosorbent assay (ELISA) immediately before and after PTCA.
- Statistical analysis was performed to compare changes in adhesion molecule concentrations between the vitamin E and placebo groups.
Main Results:
- Vitamin E supplementation significantly increased plasma alpha-tocopherol concentrations.
- In the vitamin E group, there were no significant increases in plasma sP-selectin or sICAM-1 levels post-PTCA.
- The placebo group showed a significant increase in sP-selectin post-PTCA, and this increase was significantly greater than in the vitamin E group.
Conclusions:
- Vitamin E supplementation appears to limit platelet and endothelial activation during PTCA, as evidenced by blunted increases in sP-selectin.
- These findings suggest a potential role for vitamin E in managing vascular inflammation associated with interventional cardiology procedures.
Abstract:
The soluble adhesion molecules P-selectin (sP-selectin) and intercellular adhesion molecule-1 (sICAM-1) are derived from platelets and endothelial cells. Circulating concentrations of these soluble adhesion molecules are raised in patients with atherosclerosis and following percutaneous transluminal coronary angioplasty (PTCA). We have investigated the effects of vitamin E supplements (800 IU/day) on circulating plasma ICAM-1 and P-selectin levels pre- and post-PTCA. Patients, randomized to group, were pre-treated with vitamin E or placebo (soybean oil) for 1 month before routine PTCA. Plasma sICAM-1 and sP-selectin were measured by enzyme-linked immunosorbent assay on blood taken immediately pre- and post-PTCA. Total protein and alpha-tocopherol were measured on the same samples. Plasma alpha-tocopherol concentrations increased in patients receiving vitamin E: 19.1 (1.5) [mean (standard error of the mean, SEM)] mg/mL post-PTCA versus 13.9 (0.6) mg/mL pre-PTCA (n=23; P<0.01). Plasma sP-selectin and sICAM-1 levels were not significantly increased following PTCA in the vitamin E group. Pre-angioplasty mean (SEM) plasma sP-selectin concentration in the vitamin E group was 8.83 (0.97) ng/mg protein; the corresponding mean post-angioplasty value was 9.34 (0.89) ng/mg protein (P=0.85). The mean (SEM) pre-angioplasty sICAM-1 concentration in this group was 2.18 (0.24) ng/mg protein, and was 2.20 (0.23) ng/mg protein following angioplasty (P = 0.84). In the placebo group (n = 24) there was a significant increase in mean (SEM) sP-selectin concentration following angioplasty, from 7.48 (0.73) to 9.70 (0.78) ng/mg protein (P<0.05). The change (mean, SEM) in plasma sP-selectin concentration following angioplasty was significantly greater for the placebo group [2.22 (0.50) ng/mg protein] than for the group receiving vitamin E [0.50 (0.50) ng/mg protein] (P<0.02). This difference remained significant (P<0.05) even after adjustment for pre-angioplasty P-selectin concentrations. Mean (SEM) plasma sICAM-1 concentrations remained unchanged following angioplasty [pre-angioplasty: 2.16 (0.20) ng/mg protein; post-angioplasty: 1.97 (0.13) ng/mg protein]. Vitamin E may therefore limit platelet or endothelial activation during PTCA.
More Related Videos
08:43Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
Published on: February 14, 2017
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...